Technology Opportunities

Combination of Dendritic Cell-Targeted Nano-vaccines with a Myeloid-Derived Suppressor Cell Inhibitor and Immune Checkpoint Modulators for Cancer

Ramot - code: 2-2019-1267
  • Ronit SATCHI-FAINARO, , T.A.U Tel Aviv University, Medicine-Sackler Faculty, Physiology and Pharmacology
More information can be provided upon request
Ariela Markel
VP Business Development, Healthcare
02-6586608
Ramot at Tel Aviv University Ltd. P.O. Box 39296, Tel Aviv 61392 ISRAEL
Phone: +972-3-6406608
Fax: +972-3-6406675
  • Ronit SATCHI-FAINARO (8)
Related Technologies Download page as PDF
Back